GlassScriptPhysician profile
Mark L Scripps
NPI 1114995727
$1,191.80
in general payments reported to CMS, 2019-2025
23 companies · $87.30 in 2025
The $87.30 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $160 · 2020: $125 · 2021: $166 · 2022: $182 · 2023: $206 · 2024: $265 · 2025: $87.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $558.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $558.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $144.77 | 2019-2024 | |
| Organogenesis INC. | $144.36 | 2023-2025 | Affinity, Cygnus Dual, Puraply |
| Paratek Pharmaceuticals, INC. | $111.81 | 2021-2024 | Nuzyra |
| Integra Lifesciences Corporation | $97.47 | 2019-2023 | Tenoglide |
| Convatec INC. | $90.82 | 2023 | |
| Stryker Corporation | $76.86 | 2020-2021 | |
| Nevro Corp. | $64.59 | 2024 | Senza |
| Boston Scientific Corporation | $59.46 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $54.97 | 2019 | |
| Supreme Orthopedic Systems, LLC | $49.92 | 2025 | |
| Medtronic, INC. | $43.95 | 2023 | Intellis Adaptivestim |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $34.42 | 2020 | |
| Nabriva Therapeutics, Plc | $33.77 | 2021-2022 | |
| Pfizer INC. | $27.86 | 2019-2020 | |
| Horizon Therapeutics Plc | $23.20 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenacare Global, LLC | $22.14 | 2024 | |
| Hydrofera LLC | $21.91 | 2023 | Hydrofera Blue |
| Arteriocyte Medical Systems, INC. | $21.73 | 2020 | |
| Ermi LLC | $18.88 | 2022 | |
| Sebela Pharmaceuticals INC. | $15.54 | 2019 | |
| Hikma Pharmaceuticals USA | $13.58 | 2019 | |
| Bioventus LLC | $13.38 | 2019 | |
| Orthofix Medical, INC. | $6.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Scripps listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.